Page 3 - Hong Kong (HSI) Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Aug 17, 2025

Discover Hong Kong Pharmaceuticals & Biotech Growth Stocks that are on the HSI. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

114 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
6628 Transcenta Holding	HK$4.13	35.4%	197.1%	HK$1.7b	HK$9.44	PS136.7x	E-2.4%	n/a
2105 Laekna	HK$17.50	-7.9%	273.9%	HK$6.7b	HK$26.82	PS1337.3x	E-5.3%	n/a
2256 Abbisko Cayman	HK$16.01	22.9%	428.4%	HK$10.8b	HK$15.19	PE65.9x	E-107.5%	n/a
2257 Sirnaomics	HK$9.67	16.1%	197.5%	HK$1.0b	HK$72.10	PS72.6x	S48.0%	n/a
2617 TransThera Sciences (Nanjing)	HK$54.00	25.5%	n/a	HK$21.4b	n/a	PB37.5x	n/a	n/a
9939 Kintor Pharmaceutical	HK$2.53	16.1%	169.1%	HK$1.2b	n/a	PS211.3x	n/a	n/a
2126 JW (Cayman) Therapeutics	HK$6.03	21.8%	324.6%	HK$2.4b	HK$2.40	PS14.2x	S35.4%	n/a
575 Regent Pacific Group	HK$0.85	-2.3%	88.9%	HK$248.0m	n/a	PS44.1x	n/a	n/a
1643 Modern Chinese Medicine Group	HK$0.62	-8.8%	93.8%	HK$446.4m	n/a	PE42.4x	n/a	0%
719 Shandong Xinhua Pharmaceutical	HK$8.02	-0.4%	46.9%	HK$10.5b	n/a	PE11.5x	S6.7%	3.7%
2591 Guangzhou Innogen Pharmaceutical Group	HK$52.60	n/a	n/a	HK$24.0b	n/a	PB27.7x	n/a	n/a
6887 Sunshine Lake Pharma	HK$56.95	4.9%	54.3%	HK$28.1b	n/a	PE53.5x	n/a	0%
2565 PegBio	HK$34.96	98.2%	n/a	HK$13.5b	n/a	PB237.4x	n/a	n/a
2157 Lepu Biopharma	HK$9.49	2.8%	220.6%	HK$17.1b	n/a	PS42.8x	n/a	n/a
775 CK Life Sciences Int'l. (Holdings)	HK$0.98	2.1%	188.2%	HK$9.4b	n/a	PS1.7x	n/a	0%
6118 Austar Lifesciences	HK$1.38	-9.2%	91.7%	HK$707.4m	n/a	PE40.4x	n/a	0%
897 Wai Yuen Tong Medicine Holdings	HK$0.32	3.2%	-19.0%	HK$360.0m	n/a	PE50.7x	n/a	0%
1541 ImmuneOnco Biopharmaceuticals (Shanghai)	HK$13.45	17.9%	45.2%	HK$5.5b	HK$21.89	PS63.2x	S34.6%	n/a
460 Sihuan Pharmaceutical Holdings Group	HK$1.56	9.9%	188.9%	HK$14.2b	n/a	PS6.9x	n/a	0%
2566 Hangzhou Jiuyuan Genetic Biopharmaceutical	HK$15.63	42.7%	n/a	HK$3.8b	n/a	PE25.4x	n/a	0.4%
2179 Jiangsu Recbio Technology	HK$7.79	1.2%	3.2%	HK$3.8b	n/a	PS129.6x	n/a	n/a
1011 China NT Pharma Group	HK$0.78	6.8%	140.0%	HK$525.9m	n/a	PS25.9x	n/a	0%
6978 Immunotech Biopharm	HK$4.86	18.5%	57.3%	HK$2.5b	n/a	PE-12.3x	n/a	n/a
1312 Kontafarma China Holdings	HK$0.03	0%	-9.1%	HK$167.7m	n/a	PB0.2x	n/a	0%

Page 3 of 5